Shares of Reckitt Benckiser Group plc (LON:RKT – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the seven research firms that are covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is GBX 6,242.86.
RKT has been the subject of several recent analyst reports. Royal Bank Of Canada reaffirmed a “sector perform” rating and issued a GBX 6,200 target price on shares of Reckitt Benckiser Group in a report on Wednesday, July 29th. Jefferies Financial Group reissued a “buy” rating and issued a GBX 5,900 target price on shares of Reckitt Benckiser Group in a report on Wednesday, July 29th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a GBX 5,400 price objective on shares of Reckitt Benckiser Group in a research note on Thursday. Berenberg Bank cut their price objective on shares of Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating on the stock in a research report on Friday, April 24th. Finally, Citigroup reduced their price target on Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating on the stock in a report on Thursday, April 23rd.
Get Our Latest Stock Report on Reckitt Benckiser Group
Reckitt Benckiser Group Trading Up 0.9%
Reckitt Benckiser Group (LON:RKT – Get Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The company reported GBX 101.40 EPS for the quarter. Reckitt Benckiser Group had a return on equity of 42.87% and a net margin of 21.09%. As a group, equities analysts predict that Reckitt Benckiser Group will post 331.2110727 earnings per share for the current year.
Insider Transactions at Reckitt Benckiser Group
In related news, insider Deepak Nath purchased 257 shares of the firm’s stock in a transaction dated Tuesday, June 23rd. The stock was purchased at an average price of GBX 4,650 per share, with a total value of £11,950.50. Also, insider Shannon Eisenhardt bought 432 shares of the firm’s stock in a transaction on Friday, June 12th. The shares were purchased at an average cost of £432 per share, with a total value of £186,624. Over the last three months, insiders have purchased 1,029 shares of company stock valued at $21,416,350. 0.44% of the stock is currently owned by company insiders.
About Reckitt Benckiser Group
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Featured Stories
- Five stocks we like better than Reckitt Benckiser Group
- 3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income Story
- AbbVie Quietly Solved Its Biggest Problem—Now What?
- Rio Tinto’s Results Make the Case for Looking Beyond Tech in the AI Trade
- Strategy’s Structural Strength: Hidden in a $8 Billion Illusion
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
